---
schema_version: "secwatch.filing_event.v1"
accession: "0000927066-23-000207"
form_type: "8-K"
ticker: "DVA"
cik: "0000927066"
company_name: "DAVITA INC."
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T18:41:42.089585+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# DaVita Q3 2023 adjusted EPS $2.85, revenue $3.1B, operating cash flow $661M

## Summary
- GAAP diluted EPS $2.62; adjusted diluted EPS $2.85, up from $2.08 in Q2 2023.
- Consolidated revenue $3.1 billion; operating income $496M, adjusted operating income $525M.
- Operating cash flow $661M; free cash flow $453M for the quarter.
- Nine-month 2023 net income $541M vs $492M in prior year; diluted EPS $5.80 vs $5.07.
- CEO Javier Rodriguez cited continued momentum and focus on operating discipline and patient care.

## SEC filing metadata
- accession: 0000927066-23-000207
- form_type: 8-K
- ticker: DVA
- cik: 0000927066
- company_name: DAVITA INC.
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/927066/000092706623000207/0000927066-23-000207-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/927066/000092706623000207/dva-20231107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000927066-23-000207
- JSON: https://secwatch.observer/filing/0000927066-23-000207.json
- Plain text: https://secwatch.observer/filing/0000927066-23-000207.txt

## Key facts
- Earnings Releases
  DAVITA INC. reported the quarter ended September 30, 2023 results: revenue $3.1 billion, net income $247 million, EPS $2.62.
  - Period: the quarter ended September 30, 2023
  - Revenue: $3.1 billion
  - Net income: $247 million
  - EPS: $2.62
  - Result: reported results
  source text: and delivering the highest standard of care for our patients." Financial and operating highlights for the quarter ended September 30, 2023: • Consolidated revenues were $3.1 billion. • Operating income was $496 million and adjusted operating income was $525 million. • Diluted earnings per share was $2.62 and adjusted diluted earnings per share was $2.85. •
  evidence_url: https://www.sec.gov/Archives/edgar/data/927066/000092706623000207/0000927066-23-000207-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.